<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="data-paper"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Aging Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1663-4365</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5357652</article-id><article-id pub-id-type="doi">10.3389/fnagi.2017.00064</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Data Report</subject></subj-group></subj-group></article-categories><title-group><article-title>Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Altimiras</surname><given-names>Francisco</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><xref ref-type="author-notes" rid="fn004"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/342412/overview"/></contrib><contrib contrib-type="author"><name><surname>Uszczynska-Ratajczak</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="author-notes" rid="fn004"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/402963/overview"/></contrib><contrib contrib-type="author"><name><surname>Camara</surname><given-names>Francisco</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vlasova</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/408562/overview"/></contrib><contrib contrib-type="author"><name><surname>Palumbo</surname><given-names>Emilio</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Newhouse</surname><given-names>Stephen</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Deacon</surname><given-names>Robert M. J.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Farias</surname><given-names>Leandro A. E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hurley</surname><given-names>Michael J.</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/313580/overview"/></contrib><contrib contrib-type="author"><name><surname>Loyola</surname><given-names>David E.</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/403859/overview"/></contrib><contrib contrib-type="author"><name><surname>V&#x000e1;squez</surname><given-names>Rodrigo A.</given-names></name><xref ref-type="aff" rid="aff10"><sup>10</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/15465/overview"/></contrib><contrib contrib-type="author"><name><surname>Dobson</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guig&#x000f3;</surname><given-names>Roderic</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/39733/overview"/></contrib><contrib contrib-type="author"><name><surname>Cogram</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref><xref ref-type="author-notes" rid="fn003"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/287162/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Faculty of Engineering and Sciences, Universidad Adolfo Iba&#x000f1;ez</institution><country>Santiago, Chile</country></aff><aff id="aff2"><sup>2</sup><institution>Telefonica Research and Development</institution><country>Santiago, Chile</country></aff><aff id="aff3"><sup>3</sup><institution>Centre for Genomic Regulation, Barcelona Institute of Science and Technology</institution><country>Barcelona, Spain</country></aff><aff id="aff4"><sup>4</sup><institution>Universitat Pompeu Fabra</institution><country>Barcelona, Spain</country></aff><aff id="aff5"><sup>5</sup><institution>Institute of Psychiatry, Psychology and Neuroscience, King's College London</institution><country>London, UK</country></aff><aff id="aff6"><sup>6</sup><institution>Laboratory of Molecular Neuropsychiatry, Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, National Scientific and Technical Research Council</institution><country>Buenos Aires, Argentina</country></aff><aff id="aff7"><sup>7</sup><institution>GeN.DDI Ltd</institution><country>London, UK</country></aff><aff id="aff8"><sup>8</sup><institution>Division of Brain Sciences, Centre for Neuroinflammation and Neurodegeneration, Imperial College</institution><country>London, UK</country></aff><aff id="aff9"><sup>9</sup><institution>National Center for Genomics and Bioinformatics</institution><country>Santiago, Chile</country></aff><aff id="aff10"><sup>10</sup><institution>Faculty of Sciences, Institute of Ecology and Biodiversity, Universidad de Chile</institution><country>Santiago, Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: George E. Barreto, Pontifical Xavierian University, Colombia</p></fn><fn fn-type="edited-by"><p>Reviewed by: &#x000c1;ngel M. Carri&#x000f3;n, Pablo de Olavide University, USA; Odete A. B. Da Cruz E. Silva, University of Aveiro, Portugal</p></fn><corresp id="fn001">*Correspondence: Francisco Altimiras <email xlink:type="simple">fjaltimiras@gmail.com</email></corresp><corresp id="fn002">Roderic Guig&#x000f3; <email xlink:type="simple">roderic.guigo@crg.eu</email></corresp><corresp id="fn003">Patricia Cogram <email xlink:type="simple">patricia.cogram@gmail.com</email></corresp><fn fn-type="other" id="fn004"><p>&#x02020;Shared first authorship.</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>9</volume><elocation-id>64</elocation-id><history><date date-type="received"><day>03</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>01</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Altimiras, Uszczynska-Ratajczak, Camara, Vlasova, Palumbo, Newhouse, Deacon, Farias, Hurley, Loyola, V&#x000e1;squez, Dobson, Guig&#x000f3; and Cogram.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Altimiras, Uszczynska-Ratajczak, Camara, Vlasova, Palumbo, Newhouse, Deacon, Farias, Hurley, Loyola, V&#x000e1;squez, Dobson, Guig&#x000f3; and Cogram</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><kwd-group><kwd>Alzheimer's disease</kwd><kwd><italic>Octodon degus</italic></kwd><kwd>RNA-seq</kwd><kwd>gene expression</kwd><kwd>animal models</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica<named-content content-type="fundref-id">10.13039/501100002848</named-content></funding-source><award-id rid="cn001">1090794</award-id><award-id rid="cn001">1140548</award-id><award-id rid="cn001">ICM-P05-002</award-id><award-id rid="cn001">PFB-23-CONICYT</award-id></award-group><award-group><funding-source id="cn002">Ministerio de Econom&#x000ed;a y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></funding-source><award-id rid="cn002">SEV-2012-0208</award-id></award-group><award-group><funding-source id="cn003">ISCIII - Subdirecci&#x000f3;n General de Evaluaci&#x000f3;n y Fomento de la Investigaci&#x000f3;n/FEDER &#x0201c;Una Manera de hacer Europa&#x0201d;</funding-source><award-id rid="cn003">PT13/0001/0021</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="70"/><page-count count="8"/><word-count count="7025"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Alzheimer's disease (AD) is a slowly progressive disease characterized by impairment of memory and eventually by disturbances in reasoning, planning, language, and perception. Ageing is the greatest risk factor for its development but mutations in amyloid precursor protein (APP), apolipoprotein E (APOE), microtubule-associated protein tau (MAPT) among others, are also a major factor (Blasko et al., <xref rid="B13" ref-type="bibr">2004</xref>). The symptoms of AD result from neurofibrillary tangles that are composed of aggregates of hyper-phosphorylated tau protein and an increase in the production of amyloid-beta (A&#x003b2;) protein in the brain that leads to deposits of senile plaques. As such, there is a worldwide effort to find an effective disease-modifying treatment that can reverse symptoms and/or delay onset of the disease. Transgenic mouse models exist that mimic a range of AD&#x02013;related pathologies, although none of the models fully replicate all pathological features of the human disease (Birch et al., <xref rid="B10" ref-type="bibr">2014</xref>). Drugs developed using these mouse models have failed in phase III clinical trials (Mangialasche et al., <xref rid="B46" ref-type="bibr">2010</xref>; Braidy et al., <xref rid="B14" ref-type="bibr">2012</xref>; Saraceno et al., <xref rid="B57" ref-type="bibr">2013</xref>). These failures question not only our accurate understanding of the disease (Castellani and Perry, <xref rid="B16" ref-type="bibr">2012</xref>) but also the validity of the animal models upon which the drug discovery efforts are rooted (Windisch, <xref rid="B68" ref-type="bibr">2014</xref>; Nazem et al., <xref rid="B50" ref-type="bibr">2015</xref>).</p><p>Animal models have contributed significantly to our understanding of the underlying mechanisms of AD. To date, however, these findings have not resulted in target validation in humans and successful translation to disease-modifying therapies. The <italic>Octodon degus (O. degus)</italic> is a model that naturally integrates multiple AD pathological hallmarks like tau fibrilary tangles and &#x003b2;-amyloid deposits (Inestrosa et al., <xref rid="B33" ref-type="bibr">2005</xref>, <xref rid="B34" ref-type="bibr">2015</xref>; Deacon et al., <xref rid="B21" ref-type="bibr">2015</xref>). The A&#x003b2; peptide sequence in <italic>O. degus</italic> is 97.5% homologous to the human A&#x003b2; peptide sequence (Inestrosa et al., <xref rid="B33" ref-type="bibr">2005</xref>). The species presents acetylcholine (AChE)-rich pyramidal neurons in their forebrain, which decline in numbers during the progression to an AD-like behavioral state, similar to that seen in AD patients (Ardiles et al., <xref rid="B5" ref-type="bibr">2012</xref>). Affected <italic>O. degus</italic> also present the characteristic medical signs and symptoms surrounding AD like macular degeneration, diabetes and circadian rhythm dysfunction (Laurijssens et al., <xref rid="B40" ref-type="bibr">2013</xref>). Behavioral experiments have shown that the <italic>O. degus</italic> can also present behavioral deficits and neural alterations in the frontal cortex and aggression similar to those seen in patients with AD (Tarragon et al., <xref rid="B64" ref-type="bibr">2013</xref>). Most importantly, the <italic>O. degus</italic> shows a correlation of expression with human AD- related genes making this model a powerful tool to characterize the effects of novel treatments for AD and identify new therapeutic targets. Our findings advance the use of the <italic>O. degus</italic> as an effective tool for AD research.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and methods</title><sec><title>Animals</title><p>In this study <italic>O. degus</italic> (Rodentia: Octodontidae) were captured from a natural population in central Chile, 30 km west of Santiago (Rinconada de Maip&#x000fa;, RM). In this environment, degus typically breed once per year in late autumn (May-June), with conceptions in late winter to early spring (September-October). The animals were captured as juveniles during early austral summer (November), when degus are 2&#x02013;3 months old, with mesh made traps with a Sherman-trap type mechanism. Juveniles corresponded to individuals weighing 70&#x02013;130 g (females) or 70&#x02013;140 g (males), and hence it is possible to differentiate them categorically from adults, which weight above 130 g for females, 140 g for males (Ebensperger and Hurtado, <xref rid="B25" ref-type="bibr">2005</xref>; Correa et al., <xref rid="B17" ref-type="bibr">2016</xref>).</p><p>They were housed in standard metal cages 50 &#x000d7; 40 &#x000d7; 35 cm with a layer of wood shaving as bedding and containing a small metallic box (25 &#x000d7; 15 &#x000d7; 10 cm with a single entrance), under natural photoperiod (12 h light/dark; starting 7 a.m.) and in an air-conditioned animal facility at the Faculty of Sciences, University of Chile (Santiago, Chile). They were fed with a commercial rodent diet (Prolab RMH 3000, Lab diet). Water and food were provided <italic>ad libitum</italic> during the entire experimental period. Behavioral assessment of a population (<italic>N</italic> = 84) of 3-years old <italic>O. degus</italic> was performed using the burrowing test in an earlier work (Deacon et al., <xref rid="B21" ref-type="bibr">2015</xref>), to address behavioral dysfunctions in activities of daily living (ADL) (Deacon, <xref rid="B20" ref-type="bibr">2006</xref>, <xref rid="B19" ref-type="bibr">2014</xref>). The population was divided in terms of burrowing performance into two groups: poor-burrowers (PB) and good-burrowers (GB). Brain extract samples were obtained from 8 females (four per each group). Brain soluble A&#x003b2;<sub>1&#x02212;42</sub>peptide was determined for these 8 animals by MALDI-TOF MS as described in earlier work (Deacon et al., <xref rid="B21" ref-type="bibr">2015</xref>). Samples were classified according to burrowing performance and brain soluble A&#x003b2;<sub>1&#x02212;42</sub> levels. Samples from four PB animals, with an increased level of soluble brain A&#x003b2;<sub>1&#x02212;42</sub> (AD-like group), and three samples from GB animals (with soluble levels of A&#x003b2;<sub>1&#x02212;42</sub> used as control group) were used for further analysis. Brain tissues were frozen directly in RNAlater solution (Ambion) and stored at &#x02212;80&#x000b0;C until use. All procedures of capture, transportation, maintenance and experimentation followed the recommendations of the ethics committee of the Faculty of Sciences of the University of Chile, and complied with Chilean regulations (SAG-Chilean Agriculture and Livestock Service) as well as recommendations by the Animal Behavior Society.</p></sec><sec><title>Total RNA and mRNA isolation</title><p>For total RNA extraction, PureLinkTM RNA Mini kit (Ambion, Life Technologies) was used according to the manufacturer's instructions. For genomic DNA digestion, RNase-Free DNase I (Ambion) was used. Total RNA samples were quantified in a Nanodrop 2000 spectrophotometer and integrity was evaluated by agarose gels electrophoresis with a standard protocol. For mRNA isolation from total RNA samples, MicroPoly(A) Purist kit was used according to the manufacturer's instructions. For sizing, quantitation and quality control of mRNA Bioanalyzer system (Agilent) was used, discarding samples with an RIN &#x0003c; 7.</p></sec><sec><title>RNA-sequencing</title><p>RNA-seq was performed at the National Center for Genomics and Bioinformatics (Santiago, Chile) including library preparation (using SOLiD Total RNA-seq kit), fragmentation and PCR enrichment of target mRNA according to strand-specific protocols. Two batches of paired-end (75 &#x000d7; 35 bp) library sequencing were done in a SOLiD 5,500 &#x000d7; l system (Applied Biosystems).</p></sec><sec><title>Gene prediction</title><p>We combined both <italic>ab initio</italic> and evidence-based approaches by using the Program to Assemble Spliced Alignments (PASA) and Evidence Modeler (EVM) to <italic>de novo</italic> annotate protein coding genes in <italic>O. degus</italic> genome assembly (v1.0) (Haas, <xref rid="B30" ref-type="bibr">2003</xref>). In total 25,621 transcript models were generated by PASA from an initial set of 1,767,640 sequences including (1) 26,240 <italic>O. degus</italic> mRNA transcripts and (2) 1,741,759 ESTs and mRNA sequences from four species of rodents: mouse, guinea pig, Chinese hamster and rat. Transcript sequences for all five species were derived from the GenBank NCBI databases. We also used &#x0003e;30 million UniRef90 protein clusters and 26,259 highly curated rodent-specific Swiss-Prot proteins that were split-mapped to the <italic>O. degus</italic> genome by using SPALN2 (Iwata and Gotoh, <xref rid="B35" ref-type="bibr">2012</xref>) and EXONERATE (Slater and Birney, <xref rid="B58" ref-type="bibr">2005</xref>) with mouse-specific parameters. The protein-coding gene predictions were obtained on the latest repeat-masked reference assembly of the <italic>O. degus</italic> genome by using the existing mammalian-specific parameter files of four <italic>ab initio</italic> gene prediction programs: Augustus, Geneid, SGP2, and SNA (Guig&#x000f3; et al., <xref rid="B29" ref-type="bibr">1992</xref>; Guigo et al., <xref rid="B28" ref-type="bibr">2003</xref>; Parra et al., <xref rid="B51" ref-type="bibr">2003</xref>; Stanke et al., <xref rid="B60" ref-type="bibr">2006a</xref>,<xref rid="B61" ref-type="bibr">b</xref>). For SGP2, TBLASTX (Altschul, <xref rid="B3" ref-type="bibr">1997</xref>) alignments between human (hg38) and <italic>O. degus</italic> were additionally used to improve the accuracy of gene predictions (Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>). We also used external evidence for Geneid including PASA-derived introns, while for Augustus we used both PASA-derived intron and exon hints. Performance of all programs with and without external evidence was evaluated for accuracy on an artificial scaffold made up of 238 concatenated <italic>O. degus</italic> transcripts taken from the NCBI reference annotation. The alignments (transcript and protein) and <italic>ab initio</italic> gene models were combined into consensus CDS models using Evidence Modeler (Haas et al., <xref rid="B31" ref-type="bibr">2008</xref>). The initial gene set was filtered to remove reference gene models supported exclusively by SNAP <italic>ab initio</italic> predictions. The single-exon consensus gene models derived from predictions solely supported by Geneid, SGP2 or AUGUSTUS with length &#x0003c; 300 nucleotides and an EVM score &#x0003c; 5 were also excluded. The weights of each given source were chosen empirically and based on suggestions contained in the EVM documentation. The highest weights were given to transcript alignments, followed by protein alignments and finally <italic>ab initio</italic> predictions (Augustus, Geneid, SGP2, and SNAP, Table <xref ref-type="supplementary-material" rid="SM1">S2</xref>). The consensus gene models were loaded into the PASA database and passed through five rounds of annotation updates to add UTRs and alternative splicing variants (Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>).</p></sec><sec><title>Functional annotation</title><p>Predicted protein-coding genes in the <italic>O. degus</italic> genome were further functionally annotated using an in-house developed, automatic pipeline. For each protein sequence we assigned protein signatures, orthology groups, as well as annotated metabolic pathways and reactions using an orthology-based approach. In this analysis we used InterProScan v.5 (Zdobnov and Apweiler, <xref rid="B69" ref-type="bibr">2001</xref>) to scan though all available InterPro databases, including PANTHER, Pfam, TIGRFAM, HAMAP, and SUPERFAMILY and to specify different protein coding signatures in predicted protein coding genes. The protein signatures (protein families, regions, domains, repeats and sites) were further employed to investigate the classification and to assign biological functions to predicted proteins. Blast2GO (G&#x000f6;tz et al., <xref rid="B27" ref-type="bibr">2008</xref>) analysis was used to identify GO terms for the predicted proteins, while KEGG Automatic Annotation Server (KAAS) (Moriya et al., <xref rid="B47" ref-type="bibr">2007</xref>) was employed to compare protein sequences against KEGG (Kanehisa et al., <xref rid="B38" ref-type="bibr">2012</xref>, <xref rid="B39" ref-type="bibr">2014</xref>) orthology (KO). In this analysis, KASS applied its bi-directional best hit (BBH) method in homology search against a representative gene set from 33 different species, including <italic>Mus musculus</italic> and <italic>Cricetulus griseus</italic>. KO identifiers were then used to retrieve the KEGG relevant functional annotation, such as metabolic pathways and external database references. In addition, we assigned the NCBI gene names from the <italic>O. degus</italic> reference NCBI annotation (ref_OctDeg1.0) to the predicted genes. This was done by taking NCBI gene names from the corresponding, NCBI annotated proteins, showing full sequence similarity. The sequence similarity was measured by assigning SHA1 checksum to each protein in both proteomes, followed by comparing those sums.</p></sec><sec><title>Mapping <italic>O. degus</italic> brain RNA-seq samples</title><p>The <italic>O. degus</italic> RNA Sequences were aligned to a reference transcriptome obtained from the masked primary genome assembly version 1.0 (WGS Project: AJSA01) and the EVM-based genome annotation. The transcriptome sequence was prepared using RSEM version 1.2.12 (Li and Dewey, <xref rid="B41" ref-type="bibr">2011</xref>) and projected from base space to SOLiD color space using SHRiMP version 2.2.3 (Rumble et al., <xref rid="B55" ref-type="bibr">2009</xref>). The latter program was also employed to align SOLiD 75 &#x000d7; 35 bp pair-end sequenced reads to the reference transcriptome according to the following non-default parameters: -h 80% -o 10 -p opp-in &#x02013;no-half-paired.</p></sec><sec><title>Mapping human brain RNA-seq samples</title><p>The RNA-seq data set consisting of 6 human brain samples (3 AD subjects and 3 controls, University of Kentucky brain bank) was derived from the National Center for Biotechnology Information Sequence Read Archive database (ncbi.nlm.nih.gov/sra, accession no. <ext-link ext-link-type="NCBI:sra" xlink:href="SRA060572">SRA060572</ext-link>). Next, pair-end reads were mapped to the human reference transcriptome using our in-house pipeline that combines STARv.2.4.0.1 (Dobin et al., <xref rid="B23" ref-type="bibr">2013</xref>) and RSEM version 1.2.12 (Table <xref ref-type="supplementary-material" rid="SM1">S4</xref>). The reference transcriptome was obtained from human reference genome hg38 and GENCODE v21 (Harrow et al., <xref rid="B32" ref-type="bibr">2012</xref>) as a reference annotation.</p></sec><sec><title>Expression profiling of human and <italic>O. degus</italic> brain samples</title><p>The number of reads mapped to each gene was calculated using SAMtools (Li et al., <xref rid="B42" ref-type="bibr">2009</xref>). The statistical significance of expression profile for each gene between two groups was determined using edgeR, an open source R/Bioconductor package (Robinson et al., <xref rid="B54" ref-type="bibr">2010</xref>). In this study, to estimate the significance of gene expression difference between AD or AD-like (PB) subjects and human controls or <italic>O. degus</italic> (GB) controls, the absolute value of log2 Ratio (logFC &#x02265; 1), log read count per million reads (logCPM &#x0003e; 1) and FDR &#x0003c; 0.05 were used as a criterion. Raw gene reads counts were also normalized to RPKM values (reads per kilobase per million mapped reads) using the RPKM formula described by Mortazavi et al. (<xref rid="B49" ref-type="bibr">2008</xref>).</p></sec><sec><title>GO enrichment analysis for differentially expressed genes</title><p>Functional enrichment analysis for <italic>O. degus</italic> was performed using Fisher's exact test implemented in R programming language. The GO enrichment analysis for human was also done using R. The GOstats package was used to detect the significantly enriched GO terms for DEGs, which were compared to the full GENCODE 21 gene set. For both species, we further analyzed top 20 GO terms ranked by <italic>p</italic>-value with <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Gene prediction and functional annotation</title><p>With the aim to enrich the current version of <italic>O. degus</italic> genome annotation with the new data obtained in this study, we performed <italic>de novo</italic> protein coding gene annotation. Our Evidence-Modeler (EVM) based annotation of repeat-mask <italic>O. degus</italic> genome (v1.0) resulted in prediction of 31,739 protein-coding genes, corresponding to 36,866 predicted transcripts and 36,575 proteins. The comparison of EVM-based and NCBI reference annotation revealed that the number of protein coding genes increased by 1.52-fold from 20,779 (NCBI) to 31,739 (EVM-based). Similar 1.40-fold change was reported for protein coding transcripts (26,248 for NCBI and 36,866 for EVM-based annotation) (Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>).</p><p>Each protein sequence was functionally annotated using the in house automated pipeline. Annotation features were assigned to a total of 35,618 (97%) proteins, 30,661 (97%) genes), of these 29,847 (82%) of the proteins were assigned some GO terms (Tables <xref ref-type="supplementary-material" rid="SM1">S5</xref>, <xref ref-type="supplementary-material" rid="SM1">S6</xref>, Figures <xref ref-type="supplementary-material" rid="SM1">S1</xref>, <xref ref-type="supplementary-material" rid="SM1">S2</xref>). This functional annotation, including GO terms and KEGG orthology groups, allowed us to perform enrichment analysis for genes of interest.</p></sec><sec><title>The brain transcriptome of AD-like <italic>O. degus</italic></title><p>After mapping the reads to the <italic>O. degus</italic> genome, we performed pairwise comparisons to measure the gene expression level differences between AD-like subjects and controls. As a result 54 DEGs were identified between those two groups. Statistical analysis revealed 29 genes to be up- and 25 to be down-regulated in our study (Table <xref ref-type="supplementary-material" rid="SM2">S10</xref>). The relative change in gene expression levels across AD-like and control samples is shown in Figure <xref ref-type="fig" rid="F1">1A</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>(A)</bold> Expression (FPKM values) analysis of 54 differentially expressed genes in PB group compared to GB group with two-way clustering applied. <bold>(B)</bold> Complete list of KEGG pathways corresponding to 29 up- and 25 down-regulated genes between PB and GB. Columns A and C: KEGG entry for up- and down-regulated genes, Columns B and D: Pathway names for up- and down-regulated genes. <bold>(C)</bold> Comparison of differentially expressed genes in PB vs. GB and AD-related human genes. Overall AD-correlated genes and AD-correlated genes with incipient AD stage.</p></caption><graphic xlink:href="fnagi-09-00064-g0001"/></fig><p>To determine the function of DEGs, a Gene Ontology (GO) enrichment analysis was performed (Table <xref ref-type="supplementary-material" rid="SM2">S7</xref>). The up-regulated genes were enriched notably in chromosome related processes, which include chromosome condensation and chromosome organization. GO results showed also that up-regulated genes were largely involved in amine biosynthesis, in particular biosynthesis of polyamines. In contrast, most down-regulated genes were mainly engaged in ion homeostasis related processes, such as sodium-independent organic anion transport, hyperosmotic salinity response or regulation of cellular pH reduction. To fully determine which pathways could be directly affected in AD, DEGs were analyzed using KEGG PATHWAY Database (Braidy et al., <xref rid="B14" ref-type="bibr">2012</xref>). The up-regulated genes were observed to be mainly part of signaling pathways including MAPK, Rap1, Ras and neurotransmission (cholinergic synapse), while down-regulated genes were part of pathways related to AD, Parkinson's disease and Huntington's disease (Figure <xref ref-type="fig" rid="F1">1B</xref>). Specifically down-regulation of <italic>COX8A</italic> gene. The <italic>COX8A</italic> encodes subunit VIIIA of cytochrome c oxidase, a crucial element for the formation of complex IV, which is a part of electron transport chain (ETC) in mitochondria. This is consistent with previously published data, as AD has been already linked to low activity of brain cytochrome c oxidase (Alleyne et al., <xref rid="B2" ref-type="bibr">2011</xref>; Readnower et al., <xref rid="B53" ref-type="bibr">2011</xref>). A substantial number of other down-regulated genes were also found to participate in different metabolic pathways.</p></sec><sec><title>Comparison of human and <italic>O. degus</italic> AD-like brain transcriptomes</title><p>To gain insights to how <italic>O. degus</italic> could be employed as a natural model for studying the pathogenesis of AD, a human AD brain transcriptome was analyzed using RNA-seq data derived from hippocampus tissue of AD subjects and controls (Bai et al., <xref rid="B7" ref-type="bibr">2013</xref>). Analysis of DEGs resulted in identification of 1,572 up and 1,391 down-regulated genes, which were further compared to DEGs identified for <italic>O. degus</italic> (Table <xref ref-type="supplementary-material" rid="SM2">S8</xref>). This comparison revealed overlap between seven genes, including <italic>FGF9, WISP1</italic> and <italic>CPNE7</italic> that are known to be linked with AD. Both <italic>FGF9</italic> and <italic>WISP1</italic> were observed to show the opposite expression changes for human and <italic>O. degus</italic>, while the altered expression of <italic>CPNE7</italic> was consistent between both species. Other common DEGs included one up-regulated gene: <italic>ITGBL1</italic>, and two down-regulated genes: <italic>C1orf95, LRRC55</italic>, as well as <italic>IL1RAPL2</italic>, which was down-regulated in <italic>O. degus</italic> brain and up-regulated in human hippocampus. To further compare human and <italic>O. degus</italic> AD-like brain transcriptomes, GO enrichment was employed. GO analysis revealed that that up-regulated genes for human were mainly involved in system and tissue development, in particular circulatory system and vasculature development (Table <xref ref-type="supplementary-material" rid="SM2">S9</xref>). This is to some extend consistent with biological processes described for <italic>O. degus</italic> up-regulated genes, as majority of enriched terms were biosynthesis related. Down-regulated genes were significantly enriched in neurological processes including signal transduction and neurogenesis. Similar to <italic>O. degus</italic>, AD affects glutamate secretion and glutamate receptor signaling pathways in human brain. Interestingly, genes involved in regulation of ion transport was also affected, supporting the relationship between cellular stress signals and AD.</p></sec><sec><title>Comparison of <italic>O. degus</italic> DEGs and human AD-related genes</title><p>To investigate the potential role of <italic>O. degus</italic> DEGs in human AD progression, we compared our results to a set of AD-related genes, generated using Affymetrix expression microarrays across different stages of human AD: incipient, moderate and severe, as well as control samples (Blalock et al., <xref rid="B11" ref-type="bibr">2011</xref>). AD-related genes were defined as genes, whose expression was positively or negatively correlated with results of MiniMental Status Examination (MMSE) and neurofibrillary tangles (NFT) counts across three AD categories (Blalock et al., <xref rid="B12" ref-type="bibr">2004</xref>). Interestingly, five <italic>O. degus</italic> DEGs could be linked to AD-related genes in all subjects (overall correlation) this included <italic>COX16, APOC1, ITGBL1, FGF9</italic>, and <italic>AMD1</italic>. All five DEGs correlated with MMSE scores, while three: <italic>ITGBL1, FGF9</italic>, and <italic>AMD1</italic> were both MMSE and NFT-correlated. However, only <italic>AMD1</italic> showed a similar correlation with incipient AD (Figure <xref ref-type="fig" rid="F1">1C</xref>).</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>The purpose of the present study was to characterize the brain transcriptome of the <italic>O. degus</italic> to support its use as a natural model of AD, by comparing the transcriptomes of AD-like and healthy <italic>O. degus</italic>. This study is, to the best of our knowledge, the first report of <italic>O. degus</italic> brain whole transcriptome sequencing (RNA-seq). Our results revealed in <italic>O. degus</italic> a number of genes previously implicated in AD and related disorders indicating that this model is a suitable alternative to transgenic mice models for AD research. Because the AD-pathology can vary widely with animal age we carefully matched control and AD-like groups. Animals aged 3 years have optimal AD-like pathology development namely, the presence of beta-amyloid deposits as has been previously reported (Inestrosa et al., <xref rid="B33" ref-type="bibr">2005</xref>; Ardiles et al., <xref rid="B5" ref-type="bibr">2012</xref>; Deacon et al., <xref rid="B21" ref-type="bibr">2015</xref>). This allowed for an acceptable signal dynamic for the experimental analysis. The sample size used for this study was calculated on the magnitude of the biological effect and the inherent variability of the target being measured, in this case the presence or absence of beta-amyloid deposits. We also considered the variability in the behavioral measures, which as previously reported (Deacon et al., <xref rid="B21" ref-type="bibr">2015</xref>) showed clustering in two cohort of animals, AD-like and controls in the tests of daily living.</p><p>This work has identified up-regulated genes involved in AD including the CHRNA6 gene, which encodes a sub-type of neuronal nicotinic acetylcholine receptor widely associated to AD, which are mostly linked to A&#x003b2; aggregation theory and that was found previously affected in AD patients (Lombardo and Maskos, <xref rid="B44" ref-type="bibr">2015</xref>). Another DEG AMD1 (which encodes an intermediate enzyme relevant to the polyamine biosynthesis) has an altered activity in AD and has also been implicated in schizophrenia and mood disorders, and was found up-regulated in affected AD-like <italic>O. degus</italic> (Morrison et al., <xref rid="B48" ref-type="bibr">1993</xref>; Fiori and Turecki, <xref rid="B26" ref-type="bibr">2008</xref>). The down-regulated genes found in the brains of AD-like <italic>O. degus</italic> included WNT1 inducible signaling pathway protein 1 (WISP1) (Varela-Nallar and Inestrosa, <xref rid="B65" ref-type="bibr">2013</xref>). This gene previously implicated in neurodegeneration by regulation of mitochondrial signaling and apoptosis is a downstream target in the Wnt1 signaling pathway (Wang et al., <xref rid="B66" ref-type="bibr">2012</xref>). Wnt signaling that involves Wnt1 and WISP1 is becoming recognized as a vital neuroprotective component during AD. WISP1 stops p53 mediated DNA damage and apoptosis offering neuronal protection by blocking cytochrome c release (Su et al., <xref rid="B62" ref-type="bibr">2008</xref>; Wang et al., <xref rid="B66" ref-type="bibr">2012</xref>). Mitochondrial-related genes were also found to be differentially expressed in AD-like <italic>O. degus</italic> brains, including the Cytochrome C Oxidase Subunit 8A (COX8A) that has been associated with the reduction of neuronal energy metabolism and mitochondrial dysfunction observed in AD patients by the inhibition of COX activity as a result of binding to A&#x003b2;-subunits (Lustbader et al., <xref rid="B45" ref-type="bibr">2004</xref>; Liang et al., <xref rid="B43" ref-type="bibr">2008</xref>).</p><p>The comparison of human and <italic>O. degus</italic> AD-like brain transcriptomes, revealed seven common genes that were deregulated. This included fibroblast growth factor 9 (<italic>FGF9</italic>), <italic>WISP1</italic> and Copine VII (<italic>CPNE7</italic>). Interestingly, the <italic>FGF9</italic> gene is known to be related to the MAPK pathway affected in AD patients (Antonell et al., <xref rid="B4" ref-type="bibr">2013</xref>), and is one of the therapeutic targets currently used in AD treatment (Zhang et al., <xref rid="B70" ref-type="bibr">2014</xref>).</p><p>Retinal abnormalities have also been reported to be associated to AD (Berisha et al., <xref rid="B8" ref-type="bibr">2007</xref>). <italic>O. degus</italic> naturally develops cataracts, an eye dysfunction linked to neurodegeneration (Inestrosa et al., <xref rid="B33" ref-type="bibr">2005</xref>, <xref rid="B34" ref-type="bibr">2015</xref>; Braidy et al., <xref rid="B15" ref-type="bibr">2015</xref>; Szabadfi et al., <xref rid="B63" ref-type="bibr">2015</xref>). Our study revealed deregulated expression of two genes: <italic>FRMD7</italic> and <italic>ADAMTS9</italic>, which were previously associated to retinal abnormalities. The <italic>FRMD7</italic> gene plays role in retinal and neurite development, as well as in the neuronal outgrowth. It was also connected to X-linked infantile nystagmus, a disease characterized by abnormal eye function (Betts-Henderson et al., <xref rid="B9" ref-type="bibr">2010</xref>). The <italic>ADAMTS9</italic> gene is also known to be involved in abnormal eye development. Extracellular matrix is a key mediator in the pathogenesis of age related macular degeneration and includes <italic>ADAMTS9</italic>. <italic>ADAMTS9</italic> activates <italic>AKT</italic> promoting photoreceptor degeneration and consequently membrane thickening and damage of retinal pigmentary cells. Moreover regulation of mTOR by ADAMTS9 leads to angiogenesis via VEGF A and TSP-1 this way regulating angiogenesis in the eye (Wight, <xref rid="B67" ref-type="bibr">2005</xref>; Parry et al., <xref rid="B52" ref-type="bibr">2009</xref>). Moreover, the activity disorders of ADAMTS9 regulation of the AKT/mTOR pathway leads to glycolysis and glucose uptake by increasing hypoxia-inducible factor (HIF)-1&#x003b1; (HIF1A) also been linked to AD (Avramovich-Tirosh et al., <xref rid="B6" ref-type="bibr">2010</xref>). In humans, an ADAMTS9 gene variant is associated with type 2 diabetes (T2DM) is most frequently linked with aging, cognitive impairment, AD-associated neuronal APP-A&#x003b2; deposits (de la Monte and Wands, <xref rid="B22" ref-type="bibr">2005</xref>). In relation to these results, the <italic>O. degus</italic> has insulin resistance and naturally develops type 2 diabetes and associated cataracts when fed with a diet high in glucose (Datiles and Fukui, <xref rid="B18" ref-type="bibr">1989</xref>).</p><p>We have also identified <italic>APOC-I</italic> (apolipoprotein C-I) to be deregulated in AD-like <italic>O. degus</italic> brain samples. Notably, <italic>APOC-I</italic> is part of the APOE/C-I/C-IV/C-II gene cluster on the chromosome 19 (Smit et al., <xref rid="B59" ref-type="bibr">1988</xref>) and APOE modulates its expression. This gene encodes a small apolipoprotein that is associated with A&#x003b2; plaques (Kamino et al., <xref rid="B37" ref-type="bibr">1996</xref>). APOC-I plays a critical role in CNS homeostasis, since altered expression impairs memory (Abildayeva et al., <xref rid="B1" ref-type="bibr">2008</xref>). Moreover, is to be highlighted that APOC-I co-localizes with A&#x003b2; plaques in the brain in AD (Abildayeva et al., <xref rid="B1" ref-type="bibr">2008</xref>).</p><p>The pathogenic mechanism resulting in the onset and progression of neurodegenerative diseases like AD is often associated with genetic variants and mutations and interactions with environmental impacts, lifestyle risk factors, and slowly evolving molecular changes due to aging (Jicha and Carr, <xref rid="B36" ref-type="bibr">2010</xref>; Duchen, <xref rid="B24" ref-type="bibr">2012</xref>). Thus, a number of AD research avenues could be investigated in this model other than RNA analysis. For example post-translationally through modification of protein residues like phosphorylation.</p><p>In this study we focused in whole brain, so studies of additional brain regions are needed and may point to different genes and additional pathways. The RNA-seq uncovered multiple DE transcripts, several of these are novel and some have been previously implicated in AD like WISP1 and APOC1. Being the present work a pilot study we have probably uncovered only a fraction of what these data may reveal about this model and its link with AD supporting further work with this species. Future work is underway in our laboratory to elucidate the characterization of global gene expression of young and old <italic>O. degus</italic> by analysing tissue from different brain areas. To our knowledge this is the first <italic>O. degus</italic> brain transcriptome study. Salazar et al. (<xref rid="B56" ref-type="bibr">2016</xref>), compare the sequences of genes in relation to AD using published data from <italic>O. degus</italic>, human and other rodents. They analyzed tau, APP, Apolipoprotein E (APOE), Presenilin 1 (Psen1), and A&#x003b2;-peptide sequences in correlation with specific human variants associated with AD. Their findings revealed that <italic>O. degus</italic> have the arginine substitution present in the ApoE4 pathogenic human allele; Psen1 gene showed a greater relatedness between the isoforms of human, degus, guinea pig, and mole rat, compared to those of others rodents such the rat, and also described that <italic>O. degus</italic> A&#x003b2;-peptide sequence presents high homology with the human protein, differing in only one amino acid (Salazar et al., <xref rid="B56" ref-type="bibr">2016</xref>). Furthermore, Deacon et al. (<xref rid="B21" ref-type="bibr">2015</xref>) shows that AD-like <italic>O. degus</italic> have high levels of A&#x003b2;-peptide aggregates, APP, TNF-a, IL-6, IFN-a, and the oxidative stress marker NFE2L2 when compared to healthy control <italic>O. degus</italic>, suggesting that AD-like <italic>O. degus</italic> present increased inflammation as is observed in human AD patients (Deacon et al., <xref rid="B21" ref-type="bibr">2015</xref>). Overall the study of others and the present explorative transcriptome analysis revealed that the AD-like <italic>O. degus</italic> shares common affected genes with those have been implicated in human AD and therefore provides further characterization of the <italic>O. degus</italic> as a relevant natural model. <italic>O. degus</italic> shows a correlation of expression with human AD-related genes making this model a powerful preclinical tool to characterize target effects of novel therapeutics in AD. This study provides strong evidence to support the <italic>O. degus</italic> as a valuable natural model for preclinical work in AD research.</p></sec><sec id="s5"><title>Ethics statement</title><p>This study was carried out under the approval of the ethics committee of the Faculty of Sciences, Universidad de Chile, directed by Dr. Marco M&#x000e9;ndez and integrated by:-Dr. Eduardo Friedman-Dr. Victoria Guix&#x000e9;-Dr. Madeleine Lamborot-Dr. Roberto Morales-Dr. Aurelio San Mart&#x000ed;n-Dr. Cecilia Vergara.</p></sec><sec id="s6"><title>Data availability</title><p>All the <italic>Octodon degus</italic> transcriptome data is available through the NCBI using accession <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="PRJNA326273">PRJNA326273</ext-link>.</p></sec><sec id="s7"><title>Author contributions</title><p>FA and BU contributed to the experimental procedures, data analysis and the manuscript preparation. FC, AV, EP, SN, and DL contributed to created the bioinformatic pipeline for sequencing data analysis. LF contributed to the experimental procedures and data analysis. RMJD, MH, and RD contributed to comprehensive analysis of the results and to the manuscript preparation. RV, RG, and PC contributed to the funding of the project, the experimental design and the manuscript preparation.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>This research was funded by GeN.DDI Ltd (London, UK) and by the Chilean National Commission for Scientific and Technological Research Grants 1090794, 1140548, ICM-P05-002 and PFB-23-CONICYT (to the Institute of Ecology and Biodiversity). Research was conducted under permit No. 5193 issued by the Servicio Agr&#x000ed;cola y Ganadero, Chile, with the supervision of the Ethics Committee of the Faculty of Sciences, Universidad de Chile. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, &#x0201c;Centro de Excelencia Severo Ochoa 2013&#x02013;2017,&#x0201d; SEV-2012-0208 and Project PT13/0001/0021 (ISCIII - Subdirecci&#x000f3;n General de Evaluaci&#x000f3;n y Fomento de la Investigaci&#x000f3;n/FEDER &#x0201c;Una Manera de hacer Europa&#x0201d;).</p></ack><sec sec-type="supplementary-material" id="s8"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnagi.2017.00064/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnagi.2017.00064/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="DataSheet1.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="SM2"><media xlink:href="DataSheet2.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abildayeva</surname><given-names>K.</given-names></name><name><surname>Berb&#x000e9;e</surname><given-names>J. F. P.</given-names></name><name><surname>Blokland</surname><given-names>A.</given-names></name><name><surname>Jansen</surname><given-names>P. J.</given-names></name><name><surname>Hoek</surname><given-names>F. J.</given-names></name><name><surname>Meijer</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Human apolipoprotein C-I expression in mice impairs learning and memory functions</article-title>. <source>J. Lipid Res</source>. <volume>49</volume>, <fpage>856</fpage>&#x02013;<lpage>869</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M700518-JLR200</pub-id><?supplied-pmid 18160739?><pub-id pub-id-type="pmid">18160739</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alleyne</surname><given-names>T.</given-names></name><name><surname>Mohan</surname><given-names>N.</given-names></name><name><surname>Joseph</surname><given-names>J.</given-names></name><name><surname>Adogwa</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Unraveling the role of metal ions and low catalytic activity of cytochrome C oxidase in Alzheimer's disease</article-title>. <source>J. Mol. Neurosci</source>. <volume>43</volume>, <fpage>284</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-010-9436-8</pub-id><?supplied-pmid 20725867?><pub-id pub-id-type="pmid">20725867</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>S.</given-names></name></person-group> (<year>1997</year>). <article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title>. <source>Nucleic Acids Res.</source>
<volume>25</volume>, <fpage>3389</fpage>&#x02013;<lpage>3402</lpage>. <pub-id pub-id-type="doi">10.1093/nar/25.17.3389</pub-id><?supplied-pmid 9254694?><pub-id pub-id-type="pmid">9254694</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonell</surname><given-names>A.</given-names></name><name><surname>Llad&#x000f3;</surname><given-names>A.</given-names></name><name><surname>Altirriba</surname><given-names>J.</given-names></name><name><surname>Botta-Orfila</surname><given-names>T.</given-names></name><name><surname>Balasa</surname><given-names>M.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease</article-title>. <source>Neurobiol. Aging</source>
<volume>34</volume>, <fpage>1772</fpage>&#x02013;<lpage>1778</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.12.026</pub-id><?supplied-pmid 23369545?><pub-id pub-id-type="pmid">23369545</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardiles</surname><given-names>A. O.</given-names></name><name><surname>Tapia-Rojas</surname><given-names>C. C.</given-names></name><name><surname>Mandal</surname><given-names>M.</given-names></name><name><surname>Alexandre</surname><given-names>F.</given-names></name><name><surname>Kirkwood</surname><given-names>A.</given-names></name><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>109</volume>, <fpage>13835</fpage>&#x02013;<lpage>13840</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1201209109</pub-id><?supplied-pmid 22869717?><pub-id pub-id-type="pmid">22869717</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avramovich-Tirosh</surname><given-names>Y.</given-names></name><name><surname>Bar-Am</surname><given-names>O.</given-names></name><name><surname>Amit</surname><given-names>T.</given-names></name><name><surname>Youdim</surname><given-names>M. B. H.</given-names></name><name><surname>Weinreb</surname><given-names>O.</given-names></name></person-group> (<year>2010</year>). <article-title>Up-regulation of hypoxia-inducible factor (HIF)-1&#x003b1; and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30</article-title>. <source>Curr. Alzheimer Res.</source>
<volume>7</volume>, <fpage>300</fpage>&#x02013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.2174/156720510791162403</pub-id><?supplied-pmid 20043814?><pub-id pub-id-type="pmid">20043814</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>B.</given-names></name><name><surname>Hales</surname><given-names>C. M.</given-names></name><name><surname>Chen</surname><given-names>P.-C.</given-names></name><name><surname>Gozal</surname><given-names>Y.</given-names></name><name><surname>Dammer</surname><given-names>E. B.</given-names></name><name><surname>Fritz</surname><given-names>J. J.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>110</volume>, <fpage>16562</fpage>&#x02013;<lpage>16567</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1310249110</pub-id><?supplied-pmid 24023061?><pub-id pub-id-type="pmid">24023061</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berisha</surname><given-names>F.</given-names></name><name><surname>Feke</surname><given-names>G. T.</given-names></name><name><surname>Trempe</surname><given-names>C. L.</given-names></name><name><surname>McMeel</surname><given-names>J. W.</given-names></name><name><surname>Schepens</surname><given-names>C. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Retinal abnormalities in early alzheimer's disease. investig opthalmology</article-title>
<source>Vis. Sci.</source>
<volume>48</volume>, <fpage>2285</fpage>
<pub-id pub-id-type="doi">10.1167/iovs.06-1029</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts-Henderson</surname><given-names>J.</given-names></name><name><surname>Bartesaghi</surname><given-names>S.</given-names></name><name><surname>Crosier</surname><given-names>M.</given-names></name><name><surname>Lindsay</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>H.-L.</given-names></name><name><surname>Salomoni</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development</article-title>. <source>Hum. Mol. Genet</source>. <volume>19</volume>, <fpage>342</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp500</pub-id><?supplied-pmid 19892780?><pub-id pub-id-type="pmid">19892780</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birch</surname><given-names>A. M.</given-names></name><name><surname>Katsouri</surname><given-names>L.</given-names></name><name><surname>Sastre</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Modulation of inflammation in transgenic models of Alzheimer's disease</article-title>. <source>J. Neuroinflam.</source>
<volume>11</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-11-25</pub-id><?supplied-pmid 24490742?><pub-id pub-id-type="pmid">24490742</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blalock</surname><given-names>E. M.</given-names></name><name><surname>Buechel</surname><given-names>H. M.</given-names></name><name><surname>Popovic</surname><given-names>J.</given-names></name><name><surname>Geddes</surname><given-names>J. W.</given-names></name><name><surname>Landfield</surname><given-names>P. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease</article-title>. <source>J. Chem. Neuroanat</source>. <volume>42</volume>, <fpage>118</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2011.06.007</pub-id><?supplied-pmid 21756998?><pub-id pub-id-type="pmid">21756998</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blalock</surname><given-names>E. M.</given-names></name><name><surname>Geddes</surname><given-names>J. W.</given-names></name><name><surname>Chen</surname><given-names>K. C.</given-names></name><name><surname>Porter</surname><given-names>N. M.</given-names></name><name><surname>Markesbery</surname><given-names>W. R.</given-names></name><name><surname>Landfield</surname><given-names>P. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>101</volume>, <fpage>2173</fpage>&#x02013;<lpage>2178</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308512100</pub-id><?supplied-pmid 14769913?><pub-id pub-id-type="pmid">14769913</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasko</surname><given-names>I.</given-names></name><name><surname>Stampfer-Kountchev</surname><given-names>M.</given-names></name><name><surname>Robatscher</surname><given-names>P.</given-names></name><name><surname>Veerhuis</surname><given-names>R.</given-names></name><name><surname>Eikelenboom</surname><given-names>P.</given-names></name><name><surname>Grubeck-Loebenstein</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes</article-title>. <source>Aging Cell</source>. <volume>3</volume>, <fpage>169</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9728.2004.00101.x</pub-id><?supplied-pmid 15268750?><pub-id pub-id-type="pmid">15268750</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>P.</given-names></name><name><surname>Palacios</surname><given-names>A. G.</given-names></name><name><surname>Castellano-Gonzalez</surname><given-names>G.</given-names></name><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name><name><surname>Chung</surname><given-names>R. S.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Recent rodent models for Alzheimer's disease: clinical implications and basic research</article-title>. <source>J. Neural Transm</source>. <volume>119</volume>, <fpage>173</fpage>&#x02013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-011-0731-5</pub-id><?supplied-pmid 22086139?><pub-id pub-id-type="pmid">22086139</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>Poljak</surname><given-names>A.</given-names></name><name><surname>Jayasena</surname><given-names>T.</given-names></name><name><surname>Mansour</surname><given-names>H.</given-names></name><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name><name><surname>Sachdev</surname><given-names>P. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Accelerating Alzheimer's research through &#x0201c;natural&#x0201d;animal models</article-title>. <source>Curr. Opin. Psychiatry</source>
<volume>28</volume>, <fpage>155</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1097/YCO.0000000000000137</pub-id><?supplied-pmid 25602247?><pub-id pub-id-type="pmid">25602247</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellani</surname><given-names>R. J.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress</article-title>. <source>Arch. Med. Res</source>. <volume>43</volume>, <fpage>694</fpage>&#x02013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/j.arcmed.2012.09.009</pub-id><?supplied-pmid 23085451?><pub-id pub-id-type="pmid">23085451</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>L. A.</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>C.</given-names></name><name><surname>Ram&#x000ed;rez-Estrada</surname><given-names>J.</given-names></name><name><surname>Soto-Gamboa</surname><given-names>M.</given-names></name><name><surname>Sep&#x000fa;lveda</surname><given-names>R. D.</given-names></name><name><surname>Ebensperger</surname><given-names>L. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Masculinized females produce heavier offspring in a group living rodent</article-title>. <source>J. Anim. Ecol.</source>
<volume>85</volume>, <fpage>1552</fpage>&#x02013;<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1111/1365-2656.12588</pub-id><?supplied-pmid 27589255?><pub-id pub-id-type="pmid">27589255</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datiles</surname><given-names>M. B.</given-names><suffix>III</suffix></name><name><surname>Fukui</surname><given-names>H.</given-names></name></person-group> (<year>1989</year>). <article-title>Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil</article-title>. <source>Curr. Eye Res.</source>
<volume>8</volume>, <fpage>233</fpage>&#x02013;<lpage>237</lpage>. <?supplied-pmid 2523284?><pub-id pub-id-type="pmid">2523284</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R. M. J.</given-names></name></person-group> (<year>2014</year>). <article-title>A novel approach to discovering treatments for alzheimer's disease</article-title>. <source>J. Alzheimer Dis. Park</source>. <volume>4</volume>:<fpage>142</fpage>
<pub-id pub-id-type="doi">10.4172/2161-0460.1000142</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R. M. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Burrowing in rodents: a sensitive method for detecting behavioral dysfunction</article-title>. <source>Nat. Protoc</source>. <volume>1</volume>, <fpage>118</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.19</pub-id><?supplied-pmid 17406222?><pub-id pub-id-type="pmid">17406222</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R. M. J.</given-names></name><name><surname>Altimiras</surname><given-names>F. J.</given-names></name><name><surname>Bazan-Leon</surname><given-names>E. A.</given-names></name><name><surname>Pyarasani</surname><given-names>R. D.</given-names></name><name><surname>Nachtigall</surname><given-names>F. M.</given-names></name><name><surname>Santos</surname><given-names>L. S.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Natural AD-Like neuropathology in <italic>Octodon degus</italic>: impaired burrowing and neuroinflammation</article-title>. <source>Curr. Alzheimer Res</source>. <volume>12</volume>, <fpage>314</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.2174/1567205012666150324181652</pub-id><?supplied-pmid 25817252?><pub-id pub-id-type="pmid">25817252</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Monte</surname><given-names>S. M.</given-names></name><name><surname>Wands</surname><given-names>J. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease</article-title>. <source>J. Alzheimer's Dis</source>. <volume>7</volume>, <fpage>45</fpage>&#x02013;<lpage>61</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://content.iospress.com/articles/journal-of-alzheimers-disease/jad00401">http://content.iospress.com/articles/journal-of-alzheimers-disease/jad00401</ext-link><?supplied-pmid 15750214?><pub-id pub-id-type="pmid">15750214</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>C. A.</given-names></name><name><surname>Schlesinger</surname><given-names>F.</given-names></name><name><surname>Drenkow</surname><given-names>J.</given-names></name><name><surname>Zaleski</surname><given-names>C.</given-names></name><name><surname>Jha</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>
<volume>29</volume>, <fpage>15</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><?supplied-pmid 23104886?><pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duchen</surname><given-names>M. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondria, calcium-dependent neuronal death and neurodegenerative disease</article-title>. <source>Pfl&#x000fc;gers Arch</source>. <volume>464</volume>. <fpage>111</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-012-1112-0</pub-id><?supplied-pmid 22615071?><pub-id pub-id-type="pmid">22615071</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebensperger</surname><given-names>L.</given-names></name><name><surname>Hurtado</surname><given-names>M. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Seasonal changes in the time budget of degus, <italic>Octodon degus</italic></article-title>. <source>Behaviour</source>
<volume>142</volume>, <fpage>91</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1163/1568539053627703</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiori</surname><given-names>L. M.</given-names></name><name><surname>Turecki</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Implication of the polyamine system in mental disorders</article-title>. <source>J. Psychiatry Neurosci</source>. <volume>33</volume>, <fpage>102</fpage>&#x02013;<lpage>110</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://jpn.ca/vol33-issue2/33-2-102/">http://jpn.ca/vol33-issue2/33-2-102/</ext-link><?supplied-pmid 18330456?><pub-id pub-id-type="pmid">18330456</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f6;tz</surname><given-names>S.</given-names></name><name><surname>Garc&#x000ed;a-G&#x000f3;mez</surname><given-names>J. M.</given-names></name><name><surname>Terol</surname><given-names>J.</given-names></name><name><surname>Williams</surname><given-names>T. D.</given-names></name><name><surname>Nagaraj</surname><given-names>S. H.</given-names></name><name><surname>Nueda</surname><given-names>M. J.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>High-throughput functional annotation and data mining with the Blast2GO suite</article-title>. <source>Nucleic Acids Res.</source>
<volume>36</volume>, <fpage>3420</fpage>&#x02013;<lpage>3435</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn176</pub-id><?supplied-pmid 18445632?><pub-id pub-id-type="pmid">18445632</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guigo</surname><given-names>R.</given-names></name><name><surname>Dermitzakis</surname><given-names>E. T.</given-names></name><name><surname>Agarwal</surname><given-names>P.</given-names></name><name><surname>Ponting</surname><given-names>C. P.</given-names></name><name><surname>Parra</surname><given-names>G.</given-names></name><name><surname>Reymond</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Comparison of mouse and human genomes followed by experimental verification yields an estimated 1,019 additional genes</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>100</volume>, <fpage>1140</fpage>&#x02013;<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0337561100</pub-id><?supplied-pmid 12552088?><pub-id pub-id-type="pmid">12552088</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guig&#x000f3;</surname><given-names>R.</given-names></name><name><surname>Knudsen</surname><given-names>S.</given-names></name><name><surname>Drake</surname><given-names>N.</given-names></name><name><surname>Smith</surname><given-names>T.</given-names></name></person-group> (<year>1992</year>). <article-title>Prediction of gene structure</article-title>. <source>J. Mol. Biol.</source>
<volume>226</volume>, <fpage>141</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(92)90130-C</pub-id><?supplied-pmid 1619647?><pub-id pub-id-type="pmid">1619647</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>B. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Improving the Arabidopsis genome annotation using maximal transcript alignment assemblies</article-title>. <source>Nucleic Acids Res.</source>
<volume>31</volume>, <fpage>5654</fpage>&#x02013;<lpage>5666</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg770</pub-id><?supplied-pmid 14500829?><pub-id pub-id-type="pmid">14500829</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>B. J.</given-names></name><name><surname>Salzberg</surname><given-names>S. L.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Pertea</surname><given-names>M.</given-names></name><name><surname>Allen</surname><given-names>J. E.</given-names></name><name><surname>Orvis</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Automated eukaryotic gene structure annotation using Evidencemodeler and the program to assemble spliced alignments</article-title>. <source>Genome Biol</source>. <volume>9</volume>:<fpage>R7</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2008-9-1-r7</pub-id><?supplied-pmid 18190707?><pub-id pub-id-type="pmid">18190707</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrow</surname><given-names>J.</given-names></name><name><surname>Frankish</surname><given-names>A.</given-names></name><name><surname>Gonzalez</surname><given-names>J. M.</given-names></name><name><surname>Tapanari</surname><given-names>E.</given-names></name><name><surname>Diekhans</surname><given-names>M.</given-names></name><name><surname>Kokocinski</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>GENCODE: the reference human genome annotation for The ENCODE Project</article-title>. <source>Genome Res</source>. <volume>22</volume>, <fpage>1760</fpage>&#x02013;<lpage>1774</lpage>. <pub-id pub-id-type="doi">10.1101/gr.135350.111</pub-id><?supplied-pmid 22955987?><pub-id pub-id-type="pmid">22955987</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name><name><surname>Reyes</surname><given-names>A. E.</given-names></name><name><surname>Chac&#x000f3;n</surname><given-names>M. A.</given-names></name><name><surname>Cerpa</surname><given-names>W.</given-names></name><name><surname>Villal&#x000f3;n</surname><given-names>A.</given-names></name><name><surname>Montiel</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type <italic>Octodon degu</italic></article-title>. <source>Neurobiol. Aging</source>
<volume>26</volume>, <fpage>1023</fpage>&#x02013;<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.09.016</pub-id><?supplied-pmid 15748782?><pub-id pub-id-type="pmid">15748782</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name><name><surname>R&#x000ed;os</surname><given-names>J. A.</given-names></name><name><surname>Cisternas</surname><given-names>P.</given-names></name><name><surname>Tapia-Rojas</surname><given-names>C.</given-names></name><name><surname>Rivera</surname><given-names>D. S.</given-names></name><name><surname>Braidy</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Age progression of neuropathological markers in the brain of the chilean rodent <italic>Octodon degus</italic>, a natural model of Alzheimer's disease</article-title>. <source>Brain Pathol</source>. <volume>25</volume>, <fpage>679</fpage>&#x02013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12226</pub-id><?supplied-pmid 25351914?><pub-id pub-id-type="pmid">25351914</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>H.</given-names></name><name><surname>Gotoh</surname><given-names>O.</given-names></name></person-group> (<year>2012</year>). <article-title>Benchmarking spliced alignment programs including Spaln2, an extended version of Spaln that incorporates additional species-specific features</article-title>. <source>Nucleic Acids Res</source>. <volume>40</volume>, <fpage>e161</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gks708</pub-id><?supplied-pmid 22848105?><pub-id pub-id-type="pmid">22848105</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jicha</surname><given-names>G. A.</given-names></name><name><surname>Carr</surname><given-names>S. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease</article-title>. <source>J. Alzheimer's Dis.</source>
<volume>19</volume>, <fpage>253</fpage>&#x02013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-1237</pub-id><?supplied-pmid 20061643?><pub-id pub-id-type="pmid">20061643</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamino</surname><given-names>K.</given-names></name><name><surname>Yoshiiwa</surname><given-names>A.</given-names></name><name><surname>Nishiwaki</surname><given-names>Y.</given-names></name><name><surname>Nagano</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Genetic association study between senile dementia of Alzheimer's Type and APOE/C1/C2 gene cluster</article-title>. <source>Gerontology</source>
<volume>42</volume>(<issue>Suppl. 1</issue>), <fpage>12</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1159/000213820</pub-id><?supplied-pmid 8804993?><pub-id pub-id-type="pmid">8804993</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Furumichi</surname><given-names>M.</given-names></name><name><surname>Tanabe</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>KEGG for integration and interpretation of large-scale molecular data sets</article-title>. <source>Nucleic Acids Res</source>. <volume>40</volume>(<issue>Database issue</issue>), <fpage>D109</fpage>&#x02013;<lpage>D114</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr988</pub-id><?supplied-pmid 22080510?><pub-id pub-id-type="pmid">22080510</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Kawashima</surname><given-names>M.</given-names></name><name><surname>Furumichi</surname><given-names>M.</given-names></name><name><surname>Tanabe</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Data, information, knowledge and principle: back to metabolism in KEGG</article-title>. <source>Nucleic Acids Res</source>. <volume>42</volume>(<issue>Database issue</issue>), <fpage>D199</fpage>&#x02013;<lpage>D205</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1076</pub-id><?supplied-pmid 24214961?><pub-id pub-id-type="pmid">24214961</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurijssens</surname><given-names>B.</given-names></name><name><surname>Aujard</surname><given-names>F.</given-names></name><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Animal models of Alzheimer's disease and drug development</article-title>. <source>Drug Discov. Today Technol.</source>
<volume>10</volume>, <fpage>e319</fpage>&#x02013;<lpage>e327</lpage>. <pub-id pub-id-type="doi">10.1016/j.ddtec.2012.04.001</pub-id><?supplied-pmid 24050129?><pub-id pub-id-type="pmid">24050129</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Dewey</surname><given-names>C. N.</given-names></name></person-group> (<year>2011</year>). <article-title>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</article-title>. <source>BMC Bioinformatics</source>
<volume>12</volume>:<fpage>323</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-12-323</pub-id><?supplied-pmid 21816040?><pub-id pub-id-type="pmid">21816040</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Handsaker</surname><given-names>B.</given-names></name><name><surname>Wysoker</surname><given-names>A.</given-names></name><name><surname>Fennell</surname><given-names>T.</given-names></name><name><surname>Ruan</surname><given-names>J.</given-names></name><name><surname>Homer</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>The sequence alignment/map format and SAMtools</article-title>. <source>Bioinformatics</source>. <volume>25</volume>, <fpage>2078</fpage>&#x02013;<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><?supplied-pmid 19505943?><pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>W. S.</given-names></name><name><surname>Reiman</surname><given-names>E. M.</given-names></name><name><surname>Valla</surname><given-names>J.</given-names></name><name><surname>Dunckley</surname><given-names>T.</given-names></name><name><surname>Beach</surname><given-names>T. G.</given-names></name><name><surname>Grover</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>105</volume>, <fpage>4441</fpage>&#x02013;<lpage>4446</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0709259105</pub-id><?supplied-pmid 18332434?><pub-id pub-id-type="pmid">18332434</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardo</surname><given-names>S.</given-names></name><name><surname>Maskos</surname><given-names>U.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment</article-title>. <source>Neuropharmacology</source>
<volume>96</volume>, <fpage>255</fpage>&#x02013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.11.018</pub-id><?supplied-pmid 25514383?><pub-id pub-id-type="pmid">25514383</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lustbader</surname><given-names>J. W.</given-names></name><name><surname>Cirilli</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>H. W.</given-names></name><name><surname>Takuma</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease</article-title>. <source>Science</source>
<volume>304</volume>, <fpage>448</fpage>&#x02013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1126/science.1091230</pub-id><?supplied-pmid 15087549?><pub-id pub-id-type="pmid">15087549</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangialasche</surname><given-names>F.</given-names></name><name><surname>Solomon</surname><given-names>A.</given-names></name><name><surname>Winblad</surname><given-names>B.</given-names></name><name><surname>Mecocci</surname><given-names>P.</given-names></name><name><surname>Kivipelto</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Alzheimer's disease: clinical trials and drug development</article-title>. <source>Lancet Neurol</source>. <volume>9</volume>, <fpage>702</fpage>&#x02013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70119-8</pub-id><?supplied-pmid 20610346?><pub-id pub-id-type="pmid">20610346</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriya</surname><given-names>Y.</given-names></name><name><surname>Itoh</surname><given-names>M.</given-names></name><name><surname>Okuda</surname><given-names>S.</given-names></name><name><surname>Yoshizawa</surname><given-names>A. C.</given-names></name><name><surname>Kanehisa</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>KAAS: an automatic genome annotation and pathway reconstruction server</article-title>. <source>Nucleic Acids Res</source>. <volume>35</volume>, <fpage>W182</fpage>&#x02013;<lpage>W185</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm321</pub-id><?supplied-pmid 17526522?><pub-id pub-id-type="pmid">17526522</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>L. D.</given-names></name><name><surname>Bergeron</surname><given-names>C.</given-names></name><name><surname>Kish</surname><given-names>S. J.</given-names></name></person-group> (<year>1993</year>). <article-title>Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease</article-title>. <source>Neurosci Lett.</source>
<volume>154</volume>, <fpage>141</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(93)90191-M</pub-id><?supplied-pmid 8361629?><pub-id pub-id-type="pmid">8361629</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>B. A.</given-names></name><name><surname>McCue</surname><given-names>K.</given-names></name><name><surname>Schaeffer</surname><given-names>L.</given-names></name><name><surname>Wold</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>. <source>Nat Methods</source>
<volume>5</volume>, <fpage>621</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1226</pub-id><?supplied-pmid 18516045?><pub-id pub-id-type="pmid">18516045</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazem</surname><given-names>A.</given-names></name><name><surname>Sankowski</surname><given-names>R.</given-names></name><name><surname>Bacher</surname><given-names>M.</given-names></name><name><surname>Al-Abed</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Rodent models of neuroinflammation for Alzheimer's disease</article-title>. <source>J. Neuroinflam.</source>
<volume>12</volume>, <fpage>74</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0291-y</pub-id><?supplied-pmid 25890375?><pub-id pub-id-type="pmid">25890375</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>G.</given-names></name><name><surname>Agarwal</surname><given-names>P.</given-names></name><name><surname>Abril</surname><given-names>J. F.</given-names></name><name><surname>Wiehe</surname><given-names>T.</given-names></name><name><surname>Fickett</surname><given-names>J. W.</given-names></name><name><surname>Guig&#x000f3;</surname><given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Comparative gene prediction in human and mouse</article-title>. <source>Genome Res.</source>
<volume>13</volume>, <fpage>108</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1101/gr.871403</pub-id><?supplied-pmid 12529313?><pub-id pub-id-type="pmid">12529313</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parry</surname><given-names>D. A.</given-names></name><name><surname>Toomes</surname><given-names>C.</given-names></name><name><surname>Bida</surname><given-names>L.</given-names></name><name><surname>Danciger</surname><given-names>M.</given-names></name><name><surname>Towns</surname><given-names>K. V.</given-names></name><name><surname>McKibbin</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice</article-title>. <source>Am. J. Hum. Genet.</source>
<volume>84</volume>, <fpage>683</fpage>&#x02013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2009.04.005</pub-id><?supplied-pmid 19409519?><pub-id pub-id-type="pmid">19409519</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Readnower</surname><given-names>R. D.</given-names></name><name><surname>Sauerbeck</surname><given-names>A. D.</given-names></name><name><surname>Sullivan</surname><given-names>P. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Mitochondria, Amyloid &#x003b2;, and Alzheimer's disease</article-title>. <source>Int. J. Alzheimers Dis.</source>
<volume>2011</volume>, <fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.4061/2011/104545</pub-id><?supplied-pmid 21547208?><pub-id pub-id-type="pmid">21547208</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M. D.</given-names></name><name><surname>McCarthy</surname><given-names>D. J.</given-names></name><name><surname>Smyth</surname><given-names>G. K.</given-names></name></person-group> (<year>2010</year>). <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>. <volume>26</volume>, <fpage>139</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumble</surname><given-names>S. M.</given-names></name><name><surname>Lacroute</surname><given-names>P.</given-names></name><name><surname>Dalca</surname><given-names>A. V.</given-names></name><name><surname>Fiume</surname><given-names>M.</given-names></name><name><surname>Sidow</surname><given-names>A.</given-names></name><name><surname>Brudno</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>SHRiMP: accurate mapping of short color-space reads</article-title>. <source>PLoS Comput. Biol</source>. <volume>5</volume>:<fpage>e1000386</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000386</pub-id><?supplied-pmid 19461883?><pub-id pub-id-type="pmid">19461883</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname><given-names>C.</given-names></name><name><surname>Valdivia</surname><given-names>G.</given-names></name><name><surname>Ardiles</surname><given-names>&#x000c1;. O.</given-names></name><name><surname>Ewer</surname><given-names>J.</given-names></name><name><surname>Palacios</surname><given-names>A. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic variants associated with neurodegenerative Alzheimer disease in natural models</article-title>. <source>Biol. Res.</source>
<volume>49</volume>, <fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s40659-016-0072-9</pub-id><?supplied-pmid 26919851?><pub-id pub-id-type="pmid">26919851</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraceno</surname><given-names>C.</given-names></name><name><surname>Musardo</surname><given-names>S.</given-names></name><name><surname>Marcello</surname><given-names>E.</given-names></name><name><surname>Pelucchi</surname><given-names>S.</given-names></name><name><surname>Luca</surname><given-names>M. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Modeling Alzheimer's disease: from past to future</article-title>. <source>Front. Pharmacol.</source>
<volume>4</volume>:<fpage>77</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2013.00077</pub-id><?supplied-pmid 23801962?><pub-id pub-id-type="pmid">23801962</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slater</surname><given-names>G. S. C.</given-names></name><name><surname>Birney</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Automated generation of heuristics for biological sequence comparison</article-title>. <source>BMC Bioinformatics</source>. <volume>6</volume>:<fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-6-31</pub-id><?supplied-pmid 15713233?><pub-id pub-id-type="pmid">15713233</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>M.</given-names></name><name><surname>van der Kooij-Meijs</surname><given-names>E.</given-names></name><name><surname>Frants</surname><given-names>R. R.</given-names></name><name><surname>Havekes</surname><given-names>L.</given-names></name><name><surname>Klasen</surname><given-names>E. C.</given-names></name></person-group> (<year>1988</year>). <article-title>Apolipoprotein gene cluster on chromosome 19</article-title>. <source>Hum. Genet.</source>
<volume>78</volume>, <fpage>90</fpage>&#x02013;<lpage>93</lpage>. <?supplied-pmid 2892779?><pub-id pub-id-type="pmid">2892779</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanke</surname><given-names>M.</given-names></name><name><surname>Keller</surname><given-names>O.</given-names></name><name><surname>Gunduz</surname><given-names>I.</given-names></name><name><surname>Hayes</surname><given-names>A.</given-names></name><name><surname>Waack</surname><given-names>S.</given-names></name><name><surname>Morgenstern</surname><given-names>B.</given-names></name></person-group> (<year>2006a</year>). <article-title>AUGUSTUS: ab initio prediction of alternative transcripts</article-title>. <source>Nucleic Acids Res.</source>
<volume>34</volume>(<issue>Web Server issue</issue>), <fpage>W435</fpage>&#x02013;<lpage>W439</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl200</pub-id><?supplied-pmid 16845043?><pub-id pub-id-type="pmid">16845043</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanke</surname><given-names>M.</given-names></name><name><surname>Sch&#x000f6;ffmann</surname><given-names>O.</given-names></name><name><surname>Morgenstern</surname><given-names>B.</given-names></name><name><surname>Waack</surname><given-names>S.</given-names></name></person-group> (<year>2006b</year>). <article-title>Gene prediction in eukaryotes with a generalized hidden Markov model that uses hints from external sources</article-title>. <source>BMC Bioinformatics</source>
<volume>7</volume>:<fpage>62</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-7-62</pub-id><?supplied-pmid 16469098?><pub-id pub-id-type="pmid">16469098</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y. A.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Su</surname><given-names>D. M.</given-names></name><name><surname>He</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays</article-title>. <source>Int. J. Biol. Sci</source>. <volume>4</volume>, <fpage>223</fpage>&#x02013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.4.223</pub-id><?supplied-pmid 18690294?><pub-id pub-id-type="pmid">18690294</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabadfi</surname><given-names>K.</given-names></name><name><surname>Estrada</surname><given-names>C.</given-names></name><name><surname>Fernandez-Villalba</surname><given-names>E.</given-names></name><name><surname>Tarragon</surname><given-names>E.</given-names></name><name><surname>Setalo</surname><given-names>G.</given-names></name><name><surname>Izura</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Retinal aging in the diurnal Chilean rodent (<italic>Octodon degus</italic>): histological, ultrastructural and neurochemical alterations of the vertical information processing pathway</article-title>. <source>Front. Cell Neurosci.</source>
<volume>9</volume>:<fpage>126</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00126</pub-id><?supplied-pmid 25954153?><pub-id pub-id-type="pmid">25954153</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarragon</surname><given-names>E.</given-names></name><name><surname>Lopez</surname><given-names>D.</given-names></name><name><surname>Estrada</surname><given-names>C.</given-names></name><name><surname>Ana</surname><given-names>G.-C.</given-names></name><name><surname>Schenker</surname><given-names>E.</given-names></name><name><surname>Pifferi</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title><italic>Octodon degus</italic>: a model for the cognitive impairment associated with Alzheimaer's disease</article-title>. <source>CNS Neurosci Ther</source>. <volume>19</volume>, <fpage>643</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12125</pub-id><?supplied-pmid 23710760?><pub-id pub-id-type="pmid">23710760</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela-Nallar</surname><given-names>L.</given-names></name><name><surname>Inestrosa</surname><given-names>N. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Wnt signaling in the regulation of adult hippocampal neurogenesis</article-title>. <source>Front. Cell Neurosci</source>. <volume>7</volume>:<fpage>100</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00100</pub-id><?supplied-pmid 23805076?><pub-id pub-id-type="pmid">23805076</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Chong</surname><given-names>Z. Z.</given-names></name><name><surname>Shang</surname><given-names>Y. C.</given-names></name><name><surname>Maiese</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL</article-title>. <source>Curr. Neurovasc. Res</source>. <volume>9</volume>, <fpage>20</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.2174/156720212799297137</pub-id><?supplied-pmid 22272766?><pub-id pub-id-type="pmid">22272766</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wight</surname><given-names>T. N.</given-names></name></person-group> (<year>2005</year>). <article-title>The ADAMTS proteases, extracellular matrix, and vascular disease: waking the sleeping giant(s)!</article-title>
<source>Arterioscler. Thromb. Vasc. Biol</source>. <volume>25</volume>, <fpage>12</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.0000150043.43083.aa</pub-id><?supplied-pmid 15626768?><pub-id pub-id-type="pmid">15626768</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windisch</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective</article-title>. <source>Neurodegener Dis</source>. <volume>13</volume>, <fpage>147</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1159/000357568</pub-id><?supplied-pmid 24401335?><pub-id pub-id-type="pmid">24401335</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zdobnov</surname><given-names>E. M.</given-names></name><name><surname>Apweiler</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>InterProScan&#x02013;an integration platform for the signature-recognition methods in InterPro</article-title>. <source>Bioinformatics</source>
<volume>17</volume>, <fpage>847</fpage>&#x02013;<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/17.9.847</pub-id><?supplied-pmid 11590104?><pub-id pub-id-type="pmid">11590104</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>C.</given-names></name><name><surname>Shao</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease</article-title>. <source>Int. J. Pharm</source>. <volume>461</volume>, <fpage>192</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2013.11.049</pub-id><?supplied-pmid 24300213?><pub-id pub-id-type="pmid">24300213</pub-id></mixed-citation></ref></ref-list></back></article>